SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia

Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, Nikoloz Chkhartishvili
doi: https://doi.org/10.1101/2020.09.18.20195024

Article usage

Article usage: September 2020 to July 2025

AbstractFullPdf
Sep 20207290108
Oct 2020183053
Nov 202076083
Dec 202057042
Jan 202157040
Feb 202152124
Mar 2021801239
Apr 202180032
May 202165437
Jun 202176222
Jul 202140228
Aug 202137526
Sep 202137335
Oct 202152032
Nov 202132123
Dec 202147263
Jan 202227642
Feb 202219236
Mar 202219115
Apr 202216211
May 202216018
Jun 202218114
Jul 20221607
Aug 20222138
Sep 202230120
Oct 202224012
Nov 202216110
Dec 20221316
Jan 20232245
Feb 20231758
Mar 20231202
Apr 20232217
May 202314110
Jun 2023945
Jul 2023601
Aug 202320139
Sep 20231557
Oct 20231404
Nov 2023905
Dec 20231405
Jan 2024803
Feb 20241407
Mar 20241115
Apr 20241695
May 20241211
Jun 20241534
Jul 20241315
Aug 20241247
Sep 20243017
Oct 202415510
Nov 20241906
Dec 20242128
Jan 20251546
Feb 202514132
Mar 202541268
Apr 202527211
May 20252389
Jun 20253098
Jul 202522912
Back to top
Posted September 18, 2020.
Download PDF
Data/Code
Email
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, Nikoloz Chkhartishvili
medRxiv 2020.09.18.20195024; doi: https://doi.org/10.1101/2020.09.18.20195024
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area